Diffuse Large B-Cell Lymphoma with Second Relapse in Leukemic Phase

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphomas (NHLs) and accounts for approximately one-third of all types of NHL 1 .The presence of malignant lymphoma cells in peripheral blood is well recognized in mantle cell lymphoma, follicular lymphoma, anaplastic large cell lymphoma, and the terminal phases of all refractory lymphomas 2-5 .The leukemic phase of DLBCL is a rare condition and may be difficult to distinguish from acute leukemia or other types of NHL [6][7][8][9] .The leukemic phase usually occurs as a progressive phase or in stage IV disease and is rare at the time of diagnosis in DLBC 10,11 .

Authors

Publication Details

Journal
Namık Kemal Tıp Dergisi
Published
2025-10-07
DOI
https://doi.org/10.4274/nkmj.galenos.2025.88942
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diffuse Large B-Cell Lymphoma with Second Relapse in Leukemic Phase

Hacı Hasan Esen, Si̇nan Demi̇rci̇oğlu, İpek Alemdaroğlu-Gürbüz, Atakan Teki̇nalp et al.
Namık Kemal Tıp Dergisi
Lymphoma Diagnosis and Treatment
article

Diffuse Large B-Cell Lymphoma with Second Relapse in Leukemic Phase

Hacı Hasan Esen, Si̇nan Demi̇rci̇oğlu, İpek Alemdaroğlu-Gürbüz, Atakan Teki̇nalp, Naile Kökbudak
article en

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphomas (NHLs) and accounts for approximately one-third of all types of NHL 1 .The presence of malignant lymphoma cells in peripheral blood is well recognized in mantle cell lymphoma, follicular lymphoma, anaplastic large cell lymphoma, and the terminal phases of all refractory lymphomas 2-5 .The leukemic phase of DLBCL is a rare condition and may be difficult to distinguish from acute leukemia or other types of NHL [6][7][8][9] .The leukemic phase usually occurs as a progressive phase or in stage IV disease and is rare at the time of diagnosis in DLBC 10,11 .

Namık Kemal Tıp DergisiVol. 13(3)
Openalex Percentile: Top 61%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.